We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Comfort Systems
FIX
$56.7B
| $6.52M | 0.02% |
73,300
-2,800
| -4% | -$251K |
|
552
Repligen
RGEN
$9.88B
| $6.51M | 0.02% |
34,600
-2,400
| -6% | -$456K |
|
553
BlackLine
BL
$1.67B
| $6.5M | 0.02% |
88,839
-15,475
| -15% | -$1.25M |
|
554
Denali Therapeutics
DNLI
$3.21B
| $6.45M | 0.02% |
200,568
-19,498
| -9% | -$671K |
|
555
Kinsale Capital Group
KNSL
$8.33B
| $6.43M | 0.02% |
28,200
-4,300
| -13% | -$897K |
|
|
BCYC
556
Bicycle Therapeutics
BCYC
$255M
| $6.37M | 0.02% |
145,254
+2
| +0% | +$93 |
|
557
Waste Management
WM
$87.2B
| $6.34M | 0.02% |
40,003
-224,188
| -85% | -$34M |
|
558
Citizens Financial Group
CFG
$29.2B
| $6.31M | 0.02% |
139,126
+51,666
| +59% | +$2.66M |
|
559
Generac Holdings
GNRC
$10.5B
| $6.26M | 0.02% |
21,068
-13,856
| -40% | -$4.16M |
|
|
NGM
560
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $6.26M | 0.02% |
410,268
+4
| +0% | +$62 |
|
561
American International
AIG
$39.6B
| $6.24M | 0.02% |
99,475
-599
| -0.6% | -$36K |
|
562
Dick's Sporting Goods
DKS
$11.2B
| $6.24M | 0.02% |
62,400
+17,400
| +39% | +$1.91M |
|
|
KRTX
563
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.17M | 0.02% |
48,660
-25,811
| -35% | -$2.91M |
|
|
SWTX
564
DELISTED
SpringWorks Therapeutics
SWTX
| $6.16M | 0.02% |
109,101
+1
| +0% | +$57 |
|
565
Zentalis Pharmaceuticals
ZNTL
$306M
| $6.15M | 0.02% |
133,393
+1
| +0% | +$54 |
|
566
Yeti Holdings
YETI
$2.92B
| $6.13M | 0.02% |
102,200
-5,000
| -5% | -$323K |
|
567
Rambus
RMBS
$9.07B
| $6.11M | 0.02% |
191,600
-8,300
| -4% | -$230K |
|
568
Entergy
ETR
$49.5B
| $6.07M | 0.02% |
103,982
-62,800
| -38% | -$3.44M |
|
569
East-West Bancorp
EWBC
$17.5B
| $6.07M | 0.02% |
76,800
+43,400
| +130% | +$3.66M |
|
570
Enbridge
ENB
$106B
| $6.03M | 0.02% |
130,921
+24,066
| +23% | +$1.03M |
|
571
Domino's
DPZ
$10.1B
| $6.03M | 0.02% |
14,808
-1,738
| -11% | -$758K |
|
|
MRUS
572
DELISTED
Merus
MRUS
| $6.01M | 0.02% |
227,300
-49,971
| -18% | -$1.34M |
|
573
BJs Wholesale Club
BJ
$11.9B
| $6M | 0.02% |
88,800
-67,900
| -43% | -$4.26M |
|
574
Kura Oncology
KURA
$1.02B
| $5.98M | 0.02% |
371,640
+55,788
| +18% | +$806K |
|
575
Xenon Pharmaceuticals
XENE
$5.58B
| $5.96M | 0.02% |
195,052
+4
| +0% | +$120 |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.